Literature DB >> 11856323

Dematin interacts with the Ras-guanine nucleotide exchange factor Ras-GRF2 and modulates mitogen-activated protein kinase pathways.

Mohini Lutchman1, Anthony C Kim, Li Cheng, Ian P Whitehead, S Steven Oh, Manjit Hanspal, Andrey A Boukharov, Toshihiko Hanada, Athar H Chishti.   

Abstract

Erythroid dematin is a major component of red blood cell junctional complexes that link the spectrin-actin cytoskeleton to the overlying plasma membrane. Transcripts of dematin are widely distributed including human brain, heart, lung, skeletal muscle, and kidney. In vitro, dematin binds and bundles actin filaments in a phosphorylation-dependent manner. The primary structure of dematin consists of a C-terminal domain homologous to the 'headpiece' domain of villin, an actin-binding protein of the brush border cytoskeleton. Except filamentous actin, no other binding partners of dematin have been identified. To investigate the physiological function of dematin, we employed the yeast two-hybrid assay to identify dematin-interacting proteins in the adult human brain. Here, we show that dematin interacts with the guanine nucleotide exchange factor Ras-GRF2 by yeast two-hybrid assay, and this interaction is further confirmed by blot overlay, surface plasmon resonance, co-transfection, and co-immunoprecipitation assays. Human Ras-GRF2 is expressed in a variety of tissues and, similar to other guanine nucleotide exchange factors (GEFs), displays anchorage independent growth in soft agar. Co-transfection and immunoblotting experiments revealed that dematin blocks transcriptional activation of Jun by Ras-GRF2 and activates ERK1 via a Ras-GRF2 independent pathway. Because much of the present evidence has centered on the identification of the Rho family of GTPases as key regulators of the actin cytoskeleton, the direct association between dematin and Ras-GRF2 may provide an alternate mechanism for regulating the activation of Rac and Ras GTPases via the actin cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11856323     DOI: 10.1046/j.0014-2956.2001.02694.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  The allosteric mechanism induced by protein kinase A (PKA) phosphorylation of dematin (band 4.9).

Authors:  Lin Chen; Jeffrey W Brown; Yee-Foong Mok; Danny M Hatters; C James McKnight
Journal:  J Biol Chem       Date:  2013-01-25       Impact factor: 5.157

2.  Regulatory models of RhoA suppression by dematin, a cytoskeletal adaptor protein.

Authors:  Morvarid Mohseni; Athar H Chishti
Journal:  Cell Adh Migr       Date:  2009-04-07       Impact factor: 3.405

3.  The headpiece domain of dematin regulates cell shape, motility, and wound healing by modulating RhoA activation.

Authors:  Morvarid Mohseni; Athar H Chishti
Journal:  Mol Cell Biol       Date:  2008-05-27       Impact factor: 4.272

4.  Hypermethylation of DMTN promotes the metastasis of colorectal cancer cells by regulating the actin cytoskeleton through Rac1 signaling activation.

Authors:  Ya-Ping Ye; Hong-Li Jiao; Shu-Yang Wang; Zhi-Yuan Xiao; Dan Zhang; Jun-Feng Qiu; Ling-Jie Zhang; Ya-Li Zhao; Ting-Ting Li; Wen-Ting Liao; Yan-Qing Ding
Journal:  J Exp Clin Cancer Res       Date:  2018-12-04

5.  8p21.3 deletions are rare causes of non-syndromic autism spectrum disorder.

Authors:  Nele Cosemans; Jarymke Maljaars; Annick Vogels; Maureen Holvoet; Koen Devriendt; Jean Steyaert; Kris Van Den Bogaert; Ilse Noens; Hilde Peeters
Journal:  Neurogenetics       Date:  2021-03-08       Impact factor: 2.660

6.  Human Endogenous Retrovirus-K HML-2 integration within RASGRF2 is associated with intravenous drug abuse and modulates transcription in a cell-line model.

Authors:  Timokratis Karamitros; Tara Hurst; Emanuele Marchi; Eirini Karamichali; Urania Georgopoulou; Andreas Mentis; Joey Riepsaame; Audrey Lin; Dimitrios Paraskevis; Angelos Hatzakis; John McLauchlan; Aris Katzourakis; Gkikas Magiorkinis
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-24       Impact factor: 12.779

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.